Temporal Relationships Between Circulating Levels of CC and CXC Chemokines and Developing Atherosclerosis in Apolipoprotein E*3 Leiden Mice

Increased C-C Chemokine Receptor 2 Gene Expression in Monocytes of Severe Obstructive Sleep Apnea Patients and under Intermittent Hypoxia

PDF) CC Chemokine Receptors and Chronic Inflammation-Therapeutic Opportunities and Pharmacological Challenges

Targeting the chemokine network in atherosclerosis - ScienceDirect

Macrophage-Specific IGF-1 Overexpression Reduces CXCL12 Chemokine Levels and Suppresses Atherosclerotic Burden in Apoe-Deficient Mice

Gregory BENSON, Director, BSc, PhD, Drug Development Services

Monocytic C-C chemokine receptor 5 expression increases in in vitro intermittent hypoxia condition and in severe obstructive sleep apnea patients

IJMS, Free Full-Text

References - The Design and Statistical Analysis of Animal Experiments

Frontiers Proteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation

Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease - ScienceDirect

PDF) Circulating levels of the chemokines JE and KC in female C3H apolipoprotein-E-deficient and C57BL apolipoprotein-E-deficient mice as potential markers of atherosclerosis development

Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis in mice

Temporal Relationships Between Circulating Levels of CC and CXC Chemokines and Developing Atherosclerosis in Apolipoprotein E*3 Leiden Mice

CC Chemokine Receptors and Chronic Inflammation—Therapeutic Opportunities and Pharmacological Challenges